Hormone-induced protection of mammary tumorigenesis in genetically engineered mouse models.
about
Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions.Pregnancy at early age is associated with a reduction of progesterone-responsive cells and epithelial Wnt signaling in human breast tissueParity-induced decrease in systemic growth hormone alters mammary gland signaling: a potential role in pregnancy protection from breast cancer.microRNA alterations in ALDH positive mammary epithelial cells: a crucial contributing factor towards breast cancer risk reduction in case of early pregnancy.Synthetic progestins differentially promote or prevent 7,12-dimethylbenz(a)anthracene-induced mammary tumors in sprague-dawley rats.Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer.Prevention of tumorigenesis in p53-null mammary epithelium by rexinoid bexarotene, tyrosine kinase inhibitor gefitinib, and celecoxib.Distinct luminal-type mammary carcinomas arise from orthotopic Trp53-null mammary transplantation of juvenile versus adult mice.Common integration sites for MMTV in viral induced mouse mammary tumors.Accelerated mammary maturation and differentiation, and delayed MMTVneu-induced tumorigenesis of K303R mutant ERalpha transgenic mice.Estrogen and progesterone induce persistent increases in p53-dependent apoptosis and suppress mammary tumors in BALB/c-Trp53+/- miceChemopreventive doses of methylselenocysteine alter circadian rhythm in rat mammary tissue.Parity induces differentiation and reduces Wnt/Notch signaling ratio and proliferation potential of basal stem/progenitor cells isolated from mouse mammary epitheliumExpression of Progesterone Receptor Membrane Component 1 (PGRMC1), Progestin and AdipoQ Receptor 7 (PAQPR7), and Plasminogen Activator Inhibitor 1 RNA-Binding Protein (PAIRBP1) in Glioma Spheroids In VitroEvidence that an early pregnancy causes a persistent decrease in the number of functional mammary epithelial stem cells--implications for pregnancy-induced protection against breast cancer.Triple-negative breast cancer risk in women is defined by the defect of estrogen signaling: preventive and therapeutic implicationsPregnancy-induced changes in breast cancer risk.Cancer stem cells in the human mammary gland and regulation of their differentiation by estrogen.Effects of estrogen on the proportion of stem cells in the breast.The proto-oncogene Myc is essential for mammary stem cell function.Roles for estrogen and progesterone in breast cancer prevention.Use of defatted flaxseed meal reduces precancerous colon lesions in C57BL/6 mice.Estrogen receptor-beta mediates the protective effects of aromatase induction in the MMTV-Her-2/neu x aromatase double transgenic mice.Effects of short-term estrogen treatment on the progression of N-methyl-N-nitrosourea-induced premalignant mammary lesions in female Lewis rats.Chemoprevention of LA7-Induced Mammary Tumor Growth by SM6Met, a Well-Characterized Cyclopia Extract.Genetic variation in sensitivity to estrogens and breast cancer risk.
P2860
Q33569159-72E51ACE-7D91-4EC7-B71C-66F1AF49B0FCQ33618323-81E677AD-A7D2-4C03-933F-1CD9FF2E4B6AQ33708005-44F0E408-33F7-4D31-AB03-E0D5F5A77A62Q34204974-EAFD912C-7C72-4B34-B0D6-E064D4BE261EQ34304999-A081D547-1699-4D21-8905-F6956CFE2384Q34321877-523F2C25-2F61-4C79-B028-6E6E300E8859Q34369252-7694D1E9-DC08-442C-89ED-CDE7B4C2142DQ34616600-60DC949A-5996-43B3-B63C-80D1431B0758Q35014892-51CBAA84-8D4E-4550-971C-63E24CE592CAQ35794362-AA23A178-4C93-40DA-AF21-C55627034ACFQ36787334-49632D2F-CC13-4975-B6B9-2B5AD44D444AQ36845746-CB8C8A2A-F53C-403E-B7BB-70FDF1868EB9Q36902954-C61EB7D0-8608-4295-B1D3-47E535605560Q37005277-784D6694-D3E7-4DAD-8696-998F516A3F48Q37109686-7B729901-8298-4171-B1BA-7930719B993BQ37525906-D792E321-056D-4B77-855D-93B84D6EC0D1Q37909183-E7D977D8-0AFB-4C98-BF10-F7479C0B54FFQ37913359-C06A35E8-69DC-4B27-84BA-1C6F5A4F6BD3Q39652970-AA7EAFD2-ACB1-4C0B-A8AF-922D5768A8A0Q42503855-91F97D2C-5870-49FD-BA9E-F258855186FEQ42791037-5D0D8151-E833-4B7E-9DD2-3233BF73A2E2Q43917784-361968D3-CB2D-4D04-82A0-66CD094FB33AQ46373886-E08228C1-762A-447F-9AE5-5AEC5A60ADDEQ51413042-13358643-8045-43EF-862E-E8D90B5EC5CFQ55455104-AB472E46-C11B-4DCB-A941-461136B9D576Q55521896-0C287F1F-E7A6-49E7-AA7A-9B7FD66109BC
P2860
Hormone-induced protection of mammary tumorigenesis in genetically engineered mouse models.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Hormone-induced protection of ...... cally engineered mouse models.
@ast
Hormone-induced protection of ...... cally engineered mouse models.
@en
type
label
Hormone-induced protection of ...... cally engineered mouse models.
@ast
Hormone-induced protection of ...... cally engineered mouse models.
@en
prefLabel
Hormone-induced protection of ...... cally engineered mouse models.
@ast
Hormone-induced protection of ...... cally engineered mouse models.
@en
P2093
P2860
P356
P1476
Hormone-induced protection of ...... cally engineered mouse models.
@en
P2093
Daniel Medina
Frances S Kittrell
Lakshmanaswamy Rajkumar
Powel H Brown
Raphael C Guzman
Satyabrata Nandi
P2860
P2888
P356
10.1186/BCR1645
P577
2007-01-01T00:00:00Z
P5875
P6179
1040543563